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ABSTRACT 
We report the ultrasound, computerized tomography, positron emission 
tomography and magnetic resonance imaging findings of a 38-year-old man 
with a biopsy proven solitary neurofibroma of the spermatic cord. Solitary 
neurofibromas of the male genital tract are exceedingly rare benign 
peripheral nerve sheath neoplasms composed of Schwann cells and 
fibroblasts. In contrast to schwannomas they are not bound by a capsule thus 
allowing infiltration between the nerve fascicles. Although they are benign 
lesions whose potential for malignant degeneration is very low, especially in 
the absence of neurofibromatosis type 1, accurate diagnosis is important as 
neurofibromas in this location can cause significant morbidity and 
psychological distress. Despite the extensive differential diagnosis of masses 
in the male inguinal canal, including both benign and malignant entities, a 
diagnosis of benign peripheral nerve sheath tumor can be potentially 
suggested based on imaging, particularly if MRI is performed. Surgical 
resection is the treatment of choice and the final diagnosis should be 
provided by histopathology, as was the case with this patient. 
 
 
 
 
CASE REPORT 
 
 
 
 
 
 
A 38 year-old man presented with discomfort in the right 
groin of a few weeks duration. An ultrasound (US) 
examination revealed bilateral inguinal hernias and a solitary 
well demarcated hypoechoic homogeneous mass in the right 
inguinal canal measuring 30 x 22 x 22 mm. The mass was 
richly vascularized and was in contact with the right iliac 
vessels (Fig. 1). 
 
A multidetector computed tomography (MDCT) scan and 
a positron emission tomography-computed tomography (PET-
CT) scan confirmed the presence of a solitary mass in the right 
spermatic cord with heterogeneous enhancement and moderate 
uptake of 2-deoxy-2-(18F)fluoro-D-glucose (18F-FDG) (Fig. 
2). No distant lesions were demonstrated. 
 
Magnetic resonance imaging (MRI) of the pelvis revealed 
a well demarcated and relatively homogeneous mass in the 
right spermatic cord. The mass was isointense to muscle on 
T1-weighted imaging (T1WI), hyperintense on T2-weighted 
imaging (T2WI) and showed avid and uniform enhancement 
after injection of gadolinium contrast media (Fig. 3). There 
was no diffusion restriction (Fig. 4). 
 
The patient subsequently underwent surgical resection of 
the mass by right inguinotomy, and bilateral inguinal hernia 
repair in the same instance. A preliminary assessment of the 
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surgical specimen revealed a 40 x 40 mm mass of gelatinous 
consistency. Macroscopic histopathology showed a 40 x 36 x 
23 mm well defined nodular tissue fragment weighing 13g 
(Fig. 5). Microscopically, the lesion consisted of multiple 
elongated cells with uniform oval nuclei for the most part, 
arranged in a lax richly vascularized fibrillary stroma (Fig. 6). 
Cellularity was more prominent in the central part of the lesion 
where Verocay bodies and a palisade-type of cellular 
arrangement were identified, which are typical features of 
schwannoma. No mitotic activity was found. Moreover, the 
lesion insinuated itself into the surrounding fibrofatty tissue 
without destroying it. Immunohistochemistry revealed 
expression of the S-100 protein by the tumor cells (Fig. 6). 
The histopathology diagnosis was benign neurofibroma with 
schwannoma-like elements centrally. 
 
The patient showed good recovery from surgery at a one 
month follow-up visit. However, discovery of a relatively large 
neurofibroma in a young man generated suspicion of 
neurofibromatosis type 1 (NF1). A subsequent dermatology 
assessment revealed an isolated 9 x 4 cm "café au lait" spot on 
the posterior aspect of the right thigh but no cutaneous or 
plexiform neurofibromas, axillary or inguinal freckling, or 
Lisch nodules. NF1 was therefore deemed very unlikely. 
 
 
 
 
 
Etiology & Demographics 
Neurofibromas are benign peripheral nerve sheath 
neoplasms composed of Schwann cells and fibroblasts. They 
contain a rich network of collagen fibers and in contrast to 
schwannomas they are not bound by a capsule thus allowing 
infiltration between the nerve fascicles. On 
immunohistochemistry studies, neurofibromas express the S-
100 protein. There are three types of neurofibromas: localized, 
diffuse and plexiform. The former is a well demarcated mass, 
whereas the latter presents as a diffusely infiltrating lesion 
along the course of a nerve and is pathognomonic of NF1. 
Diffuse neurofibromas occur most frequently in the 
subcutaneous soft tissues of the head and neck of children and 
young adults. Localized neurofibromas are the most common 
(90%) and the majority are solitary lesions not associated with 
NF1 [1]. In fact only 10% of patients with solitary 
neurofibromas have NF1 [2]. They occur equally in men and 
women and mostly in young patients (20-30 years) [2].  
 
Although, most solitary neurofibromas are not associated 
with neurofibromatosis type 1 [1], a solitary neurofibroma of 
the spermatic cord could potentially occur in NF1 and be the 
only clinical finding. This is described as the "forme fruste" of 
NF1 [3]. Solitary neurofibromas of the spermatic cord arise 
from the genitofemoral or ilioinguinal nerve and are 
exceedingly rare lesions. Given the rarity of solitary 
neurofibromas of the male genital tract, a meaningful 
demographic analysis is difficult to carry out. To our 
knowledge, only 14 cases of solitary neurofibromas of the 
male genital tract have been described in the literature [4-17] 
(Table 1). Of these, only nine were actually neurofibromas of 
the spermatic cord, with five being intrascrotal [5,6,8,10,16]. 
The age of the patients ranged from 8 to 86 (mean 49.5). 
 
Clinical & Imaging findings 
Neurofibromas of the spermatic cord may present as a 
palpable mass, dull aching pain, or sensory loss [18]. In our 
case, the presentation was a palpable mass in the right groin 
associated with discomfort. From the literature reviewed, only 
two out of the 14 cases reported presented with pain [9,14]. 
Severe motor weakness is not a feature of neurofibromas of the 
spermatic cord and is usually observed with malignant tumors 
[18]. Other clinical signs of malignant transformation include 
pain and rapid growth [19]. Benign neurofibromas are usually 
smaller than 5 cm at presentation, whereas neurofibromas 
which have undergone malignant degeneration are frequently 
larger [2]. 
 
On US, solitary neurofibromas usually appear as well 
defined, relatively homogeneous, predominantly hypoechoic 
masses with poor to moderate vascularization on color and 
power Doppler. Some variability has nevertheless been 
observed with some solitary neurofibromas presenting as 
heterogeneous masses and showing posterior acoustic 
shadowing [20]. On non-contrast MDCT, they may appear as 
well demarcated masses with attenuation equivalent to skeletal 
muscle [20-30 hounsfield units (HU)] that enhance after 
administration of iodinated contrast media (CM) [21]. 
Enhancement is more pronounced in larger lesions [2]. On 
PET-CT, benign neurofibromas do not usually show increased 
uptake of the 18F-FDG radiotracer in keeping with their 
benign nature. A high standardized uptake value (SUV) may 
however be observed in case of malignant degeneration. 
Benign nerve sheath tumors may nevertheless show mildly 
increased 18F-FDG uptake, but uptake in malignant nerve 
sheath tumors is significantly higher (mean maximum SUV 8.5 
versus 1.5, respectively) [22]. MRI is the modality of choice 
for the characterization of neurofibromas as it allows exquisite 
anatomical analysis of the lesion and its relation to the 
surrounding soft tissues as well as assessment of its 
enhancement dynamics and internal water diffusion restriction 
properties. This in turn enables characterization of the lesion 
as benign or malignant with a high degree of certainty. On 
MRI, neurofibromas usually appear as a mass which is 
isointense on T1WI and hyperintense on T2WI in relation to 
muscle [2]. However, a hyperintense rim and central area of 
low signal ("target sign") may also be seen on T2WI, which is 
thought to be due to a central area of collagenous stroma of 
increased density and condensed Schwann cells [2]. This sign 
is highly suggestive of neurofibroma, but may also be 
observed in schwannomas and malignant peripheral nerve 
sheath tumors [2]. Imaging signs of malignant transformation 
on MRI include T2WI heterogeneity and absence of the target 
sign [21]. Other signs of malignant degeneration include rapid 
increase in size, heterogeneity also on T1WI, intralesional 
hemorrhage or necrosis and peripheral enhancement [23-26]. 
The pattern of enhancement varies in benign and malignant 
peripheral nerve sheath tumors. In most cases, malignant 
lesions show increased heterogeneous enhancement, which is 
typically nodular and peripheral [27]. This is due to the 
presence of intratumoral hemorrhage and necrosis in malignant 
lesions [26]. Lesions that demonstrate the target sign typically 
DISCUSSION 
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21 
enhance more avidly in the central region [27]. Diffusion-
weighted imaging (DWI) in correlation with the apparent 
diffusion coefficient (ADC) map of peripheral nerve sheath 
tumors has also proved useful in characterizing these lesions as 
benign or malignant with the latter showing low water 
diffusivity values [28]. 
 
Treatment & Prognosis 
Solitary neurofibromas which are not associated with NF1 
are usually treated by surgical excision. However, as they are 
unencapsulated and infiltrate between the nerve fascicles, 
sacrifice of the parent nerve is necessary. This is why 
conservative treatment or incomplete excision are preferred in 
deep seated lesions or those occurring in important nerves in 
order to minimize neurological injury and permanent damage 
[2]. 
 
The prognosis of solitary neurofibromas is usually 
excellent. Malignant degeneration is very rare in the absence 
of NF1 and only 4% in NF1 patients [2]. Local recurrence is 
uncommon in lesions not associated with NF1 [1]. 
  
Differential Diagnosis 
The differential diagnosis of a mass in the male inguinal 
canal is relatively vast and for the most part comprising benign 
lesions or herniation of normal anatomical structures such as 
bowel hernias. Benign masses of the inguinal canal in men 
include lipoma, hematoma, abscess and desmoid tumor of the 
spermatic cord. Malignant processes of the male inguinal 
region include liposarcoma, Burkitt lymphoma, testicular 
carcinoma, sarcoma, and metastases [21]. All of these benign 
and malignant entities are more common that solitary 
neurofibroma. 
 
Lipomas are usually obvious lesions on imaging, 
especially on MDCT and MRI as they have the same 
appearance as subcutaneous fat. Differentiation from 
liposarcoma may however be challenging, especially if the 
latter is well differentiated, in which case it will appear as a 
mass of fat attenuation and intensity on MDCT and MRI, 
respectively. Hematomas of the inguinal canal occur mainly as 
a result of trauma and/or anticoagulation therapy, and the 
diagnosis should be readily apparent based on the history and 
the typical imaging appearance of blood. The same applies to 
an abscess of the inguinal canal which can be secondary to an 
incarcerated and/or perforated hernia, diverticulitis or Meckel 
diverticulum and is accompanied by a typical clinical scenario 
including groin pain, fever and raised inflammatory markers. 
Desmoid tumors are associated with Gardner syndrome, 
familial adenomatous polyposis, and surgical scars [29]. 
Differentiation from neurofibroma may be difficult as desmoid 
tumors show low attenuation on MDCT, are hypointense on 
T1WI, and enhance after administration of contrast media. 
However, low or heterogeneous signal intensity on T2WI 
should enable differentiation from neurofibroma [21]. Burkitt 
lymphoma is a high-grade form of non-Hodgkin lymphoma 
which presents as heterogeneous enhancement of the spermatic 
cord [21] as opposed to the well defined nature of solitary 
neurofibromas. Testicular carcinoma is a relatively uncommon 
malignancy in men that spreads to the spermatic cord by 
hematogenous dissemination or direct invasion. Identification 
of an intratesticular mass on ultrasound imaging in a patient 
should promptly suggest the diagnosis of testicular cancer, 
especially if associated with retroperitoneal lymphadenopathy 
on MDCT. Sarcoma of the inguinal canal is a rare tumor that 
presents as a firm, palpable mass that despite its nonspecific 
imaging appearance should not be mistaken for a benign 
process given its invasive nature, often extending into the 
abdomen [21]. 
 
The most common primaries associated with metastases to 
the inguinal canal are alveolar rhabdomyosarcoma and 
monophasic sarcoma, prostate cancer, Wilms tumor, carcinoid 
tumor, melanoma, and pancreatic cancer. In a patient with a 
known malignancy, a mass in the inguinal canal is considered 
a metastasis until proven otherwise, and indicates stage 4 
disease if peritoneal carcinomatosis is absent [21]. 
 
 
 
 
 
Solitary neurofibroma needs to be considered in the 
differential diagnosis of a mass of the male inguinal canal 
despite the extreme rarity of this entity. MRI is the modality of 
choice to confirm the presence and to characterize a tumor in 
this location due to its ability to exquisitely depict soft tissues 
and its multiplanar capabilities.  Since malignant degeneration 
of solitary neurofibromas and local recurrence after resection 
are extremely rare in the absence of NF1, surgical management 
is curative. 
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Figure 1: 38-year-old man with neurofibroma of the right spermatic cord. A and B: Sagittal and axial US images, respectively, 
through the right inguinal region demonstrate a 30 x 22 x 22 mm solid, well-demarcated, relatively homogeneous mass in the 
spermatic cord. The axial image (B) shows the mass is in contact with the right external iliac artery (arrow) but no vascular 
compression or invasion. C: Color Doppler imaging shows moderate vascularization of the mass. TECHNIQUE: US (Philips 
Medical Systems iU22), color Doppler, 12 MHz transducer. 
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Figure 2: 38-year-old man with neurofibroma of the right spermatic cord. A and B: Coronal reconstruction image and axial 
contrast enhanced MDCT image, respectively, in the venous phase show a 41 x 32 x 30 mm well-delineated oval mass of the right 
spermatic cord (arrows) with heterogeneous enhancement which is more pronounced centrally. The mass is in contact with the 
right external iliac vessels but no vascular compression or invasion are demonstrated. C: Axial non-enhanced PET-CT fused 
image through the inguinal region shows the right spermatic cord mass (arrow) with only moderate uptake of the radiotracer 
(maximum SUV of 2.4). TECHNIQUE: MDCT (Siemens Biograph 64), 120 kV. Images A and B: 2 mm slice thickness, 381 
mAs, 100 ml of Iohexol 350 (Accupaque® 350) contrast media. Image C: 5 mm slice thickness, 101 mAs, non-contrast, 370 MBq 
of 18F- FDG. 
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Figure 3: 38-year-old man with neurofibroma of the right spermatic cord. A: Axial T1W MR image through the inguinal region 
shows a well-demarcated homogeneous mass of the right spermatic cord (arrow) coming into contact with the right external iliac 
vessels without compression or invasion of the latter. The mass is nearly isointense to muscle and measures 28 x 27 mm in the 
axial plane. B: Axial T2W MR image shows the right spermatic cord mass (arrow) which is uniformly hyperintense to muscle and 
even to the surrounding fat. C and D: Axial T1W MR image after intravenous injection of gadolinium contrast media and digital 
subtraction image, respectively, demonstrate avid and homogeneous enhancement of the right spermatic cord mass (arrow). 
TECHNIQUE: 1.5 Tesla MRI (Philips Medical Systems Achieva), 4 mm slice thickness. Image A: TR 671.4 ms, TE 18 ms, non-
contrast. Image B: TR 3974.9 ms, TE 130 ms, non-contrast. Images C and D: TR 671.4 ms, TE 18 ms, 13 ml of Gadoterate 
Meglumine (Dotarem®). 
 
 
Figure 4: 38-year-old man with neurofibroma of the right spermatic cord. A, B and C: Axial MR diffusion-weighted imaging 
(DWI) at b0, b500 and b1000 (A, B, and C, respectively) through the inguinal region shows hyperintensity of the right spermatic 
cord mass at b0 which decreases at b500 and virtually disappears at b1000 (arrows). D: Axial MR apparent diffusion coefficient 
(ADC) image shows high ADC values in the lesion (arrow), which confirms an absence of water diffusion restriction. 
TECHNIQUE: 1.5 Tesla MRI (Philips Medical Systems Achieva), TR 2000 ms, TE 70 ms, 5 mm slice thickness, non-contrast. 
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Figure 6: 38-year-old man with neurofibroma of the right spermatic cord. A: Micropathology photograph (x100) demonstrates 
multiple elongated cells with uniform oval nuclei for the most part, arranged in a lax richly vascularized fibrillary stroma. No 
mitotic activity is seen. B: Micropathology photograph (x200) of the central part of the lesion shows increased cellularity and a 
palisade-type of cellular arrangement, which are histological features of schwannoma. Again, no mitotic activity is identified. C: 
Micropathology photograph (x100) at the margin of the mass shows the tumor insinuating itself into the surrounding fibrofatty 
tissue (arrows) without destroying it. D: Immunohistochemistry photographs (x200) reveal expression of the S-100 protein by the 
tumor cells (seen as brown coloration). 
 
 
 
 
 
 
 
 
 
Figure 5 (left): 38-year-old man with neurofibroma of the 
right spermatic cord. Gross pathology photograph shows an 
oval 40 x 36 x 23 mm well-defined nodular tissue fragment 
weighing 13g. 
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Study 
Year of 
publication 
Tumor origin 
Age 
(years) 
Tumor dimensions 
(cm) 
Schulte et al. [3] 1939 Spermatic cord 49 13 x 10 x 8 
Levant and Chetlin [4] 1948 Tunica albuginea 59 1 x 0.5 x 0.3 
Livolsi and Schiff [5] 1948 Intratesticular 23 9 x 7 x 4 
Johnson et al. [6] 1975 Spermatic cord 65 5 in greatest diameter 
Yamamoto et al. [7] 1982 Scrotum (subcutaneous)   8 5 x 1.5 x 1.5 
Sánchez-Chapado et al. [8] 1988 Spermatic cord 66 11 x 6 
Yoshimura et al. [9] 1990 Scrotum 41 5 x 3.5 x 3 
Issa et al. [10] 1993 Genitofemoral nerve 77 13 x 4.5 x 3 
Pelice et al. [11] 1994 Spermatic cord 55 8.4 (diameter) 
Deliveliotis et al. [12] 2002 Spermatic cord 74 4 x 4 x 1 
Milathianakis et al. [13] 2004 Spermatic cord 86 5 x 4 x 2.5 
Turkyilmaz et al. [14] 2004 Genitofemoral nerve 14 9.5 x 7 x 4.5 
Gupta et al. [15] 2011 Scrotum 24 10 x 9 
Hosseini et al. [16] 2012 Spermatic cord 52 9 x 4.5 
This case 2014 Spermatic cord 38 4 x 3.6 x 2.3 
 
Table 1: Patients with solitary neurofibroma of the male genital tract. 
Etiology 
Benign peripheral nerve sheath neoplasm composed of Schwann cells and fibroblasts containing a 
rich network of collagen fibers, which arises from the genitofemoral or ilioinguinal nerve. In 
contrast to schwannomas they are not bound by a capsule thus allowing infiltration between the 
nerve fascicles. 
Incidence Very rare. Only 14 cases reported in the literature. 
Gender ratio Only men. 
Age predilection Occurs primarily in the first two decades of life. Reported ages are 8 to 86 (mean 49.5). 
Treatment 
Usually treated by surgical excision. However, as they are unencapsulated and infiltrate between the 
nerve fascicles, sacrifice of the parent nerve is necessary. This is why conservative treatment or 
incomplete excision are preferred in deep seated lesions or those that arise from important nerves.  
Prognosis 
Usually excellent. Malignant degeneration is very rare in the absence of NF1. Local recurrence is 
uncommon. 
Imaging findings 
US: well defined, relatively homogeneous, predominantly hypoechoic mass with poor to moderate 
vascularization on color and power Doppler.  
MDCT: well demarcated mass with attenuation equivalent to skeletal muscle that enhances after 
administration of iodinated contrast media.  
MRI: T1 isointense and T2 hyperintense to muscle. However, a hyperintense rim and central area of 
low signal (“target sign”) may be seen which is highly suggestive of neurofibroma. Variable 
enhancement pattern. 
 
Table 2: Summary table for solitary neurofibroma of the male genital tract. 
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28 
Entity US findings MDCT findings MRI findings 
Solitary 
neurofibroma 
 Well defined, relatively 
homogeneous, 
predominantly hypoechoic 
mass 
 Poor to moderate 
vascularisation on color and 
power Doppler 
 Well demarcated 
 Attenuation equivalent to skeletal 
muscle 
 Contrast enhancement, especially 
larger lesions 
 T1 isointense to muscle 
 T2 hyperintense compared to fat 
 “Target sign” is highly suggestive of 
diagnosis 
 Contrast enhancement variable and 
often peripheral 
 No diffusion restriction 
Lipoma 
 Variable echogenicity 
 Difficult to identify if 
unencapsulated 
 Well demarcated 
 Low attenuation equivalent to fat 
 No contrast enhancement 
 T1 hyperintense 
 T2 hyperintense 
 No contrast enhancement 
Hematoma 
 Acute: low echogenicity 
 Chronic: septae formation, 
solid appearance, 
calcifications 
 Acute: high attenuation with 
possibly fluid-fluid level 
 Chronic: may resemble abscess 
 Acute: T1 isointense, T2 hypointense 
 Subacute: T1 and T2 hyperintense 
 Chronic: T1 and T2 hypointense 
Abscess 
 Echogenic fluid collection 
 Hyperechogenic capsule 
 Low attenuation mass 
 Rim enhancement 
 T1 hypointense 
 T2 hyperintense 
 May show thin rim of contrast 
enhancement 
Desmoid tumor 
 Homogeneously isoechoic 
masses 
 May be mistaken for cysts 
 Low attenuation soft tissue mass 
 Homogeneous contrast 
enhancement 
 T1 hypointense 
 T2 hypointense or heterogeneous 
signal intensity 
 Contrast enhancement 
Liposarcoma  Variable echogenicity 
 Well-differentiated: mass of fat 
attenuation with thick septa of soft 
tissue attenuation 
 Dedifferentiated: heterogeneously 
enhancing soft tissue components 
with calcifications 
 Well-differentiated: T1 hyperintense, 
T2 hyperintense, little contrast 
enhancement 
 Dedifferentiated: nonspecific imaging 
features, heterogeneously enhancing 
soft tissue components 
Burkitt lymphoma 
 Thickening of the spermatic 
cord in the inguinal canal 
 Thickening of the spermatic cord in 
the inguinal canal 
 Diffuse heterogeneous 
enhancement 
 Thickening of the spermatic cord in 
the inguinal canal 
 Diffuse heterogeneous enhancement 
Testicular carcinoma 
(infiltration of the 
spermatic cord) 
 Nodular and cystic lesions 
in the spermatic cord 
 Enhancing solid components 
 Nonenhancing cystic component 
 T1 and T2 heterogeneous signal 
intensity 
 Contrast enhancement 
Sarcoma 
 Mass infiltrating the 
spermatic cord 
 Enhancing mass infiltrating the 
spermatic cord 
 May extend into the abdomen 
 Imaging findings non-specific 
Metastases  Masses in the inguinal canal  Usually enhancing masses 
 T1 and T2 characteristics depend on 
the primary 
 Usually enhancing masses 
 
Table 3: Differential diagnosis for solitary neurofibroma of the spermatic cord. 
 
 
18F-FDG = 2-deoxy-2-(18F)fluoro-D-glucose 
ADC = apparent diffusion coefficient 
CM = contrast media 
DWI = diffusion-weighted imaging 
HU = Hounsfield unit 
MDCT = multidetector computed tomography 
MRI = magnetic resonance imaging 
NF1 = neurofibromatosis type 1 
PET-CT = positron emission tomography-computed 
tomography 
T1WI = T1-weighted imaging 
T2WI = T2-weighted imaging 
US = ultrasound 
 
 
 
neurofibroma; spermatic cord; male genital tract; ultrasound; 
MDCT; MRI 
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